112 related articles for article (PubMed ID: 1763815)
1. Alteration of the mammotroph Golgi complex by the dopamine agonist 2 Br-alpha-ergocryptine (CB-154) in ovariectomized estrogen primed rats.
Poole MC; Easley CS; Hodson CA
Anat Rec; 1991 Nov; 231(3):339-46. PubMed ID: 1763815
[TBL] [Abstract][Full Text] [Related]
2. Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.
Maeda T; Sawada K; Itoh Y; Moriwaki K; Mori H
Lab Invest; 1991 Dec; 65(6):679-87. PubMed ID: 1753713
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-induced physical barrier to inhibit prolactin release in mammotrophs disappears during resumption of prolactin secretion.
Reifel CW; Shin SH; Saunders SL
Neuroendocrinology; 1985 May; 40(5):438-43. PubMed ID: 4010889
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
[TBL] [Abstract][Full Text] [Related]
5. Changes of cell morphology and prolactin secretion induced by 2-Br-alpha-ergocryptine, estradiol, and thyrotropin-releasing hormone in rat anterior pituitary cells in culture.
Antakly T; Pelletier G; Zeytinoglu F; Labrie F
J Cell Biol; 1980 Aug; 86(2):377-87. PubMed ID: 6772648
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of galanin and prolactin within secretory granules of anterior pituitary cells in estrogen-treated Fischer 344 rats.
Hyde JF; Engle MG; Maley BE
Endocrinology; 1991 Jul; 129(1):270-6. PubMed ID: 1711463
[TBL] [Abstract][Full Text] [Related]
7. Morphology of the mammotrophs and gonadotrophs in the anterior pituitary gland of rats with protein-calorie malnutrition.
Herbert DC
Am J Anat; 1980 Aug; 158(4):521-31. PubMed ID: 6779621
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of pituitary lactotrophs: immunocytochemical identification of functional subtypes.
De Paul AL; Pons P; Aoki A; Torres AI
Acta Histochem; 1997 Aug; 99(3):277-89. PubMed ID: 9381911
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph.
Conconi MV; Walker AM
Endocrinology; 1984 Mar; 114(3):725-34. PubMed ID: 6697960
[TBL] [Abstract][Full Text] [Related]
10. Age-related alterations in the number and function of pituitary lactotropic cells from intact and ovariectomized rats.
Chuknyiska RS; Blackman MR; Hymer WC; Roth GS
Endocrinology; 1986 May; 118(5):1856-62. PubMed ID: 3698899
[TBL] [Abstract][Full Text] [Related]
11. Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.
McComb DJ; Hellmann P; Thorner MO; Scott D; Evans WS; Kovacs K
Am J Pathol; 1986 Jan; 122(1):7-16. PubMed ID: 3942200
[TBL] [Abstract][Full Text] [Related]
12. Cytosuppressive effect of bromocriptine on human prolactinomas: stereological analysis of ultrastructural alterations with special reference to secretory granules.
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Cancer Res; 1986 Mar; 46(3):1507-12. PubMed ID: 3943108
[TBL] [Abstract][Full Text] [Related]
13. Effect of acrylonitrile on the rat pituitary: enlargement of Golgi region in prolactin cells, crinophagy in prolactin cells and growth hormone cells.
Kamijo K; Kovacs K; Szabo S; Bollinger-Gruber JN; Reichlin S
Br J Exp Pathol; 1986 Jun; 67(3):439-51. PubMed ID: 3718845
[TBL] [Abstract][Full Text] [Related]
14. Effects of bromocriptine on pituitary organelle marker enzyme activities in lactating and postlactating rats: selective activation of lysosomal prolactin proteolytic activity.
De Marco L; Mashiter K; Caughey B; Peters TJ
Endocrinology; 1984 Sep; 115(3):984-9. PubMed ID: 6086293
[TBL] [Abstract][Full Text] [Related]
15. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
Anthony PK; Stoltz RA; Pucci ML; Powers CA
Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
[TBL] [Abstract][Full Text] [Related]
16. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
Shull JD; Gorski J
Mol Pharmacol; 1990 Feb; 37(2):215-21. PubMed ID: 1968222
[TBL] [Abstract][Full Text] [Related]
17. Intracellular dynamics in pituitary mammotropes throughout the rat estrous cycle. II. Changes in synthetic and secretory organelles.
Poole MC; Mahesh VB; Costoff A
Am J Anat; 1980 May; 158(1):15-28. PubMed ID: 7191202
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid profiles in hepatic membranes of rats with different levels of circulating estrogen and prolactin.
Bellini MJ; Carino MH; Tacconi-Gómez Dumm N; Goya RG
Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):470-4. PubMed ID: 16490375
[TBL] [Abstract][Full Text] [Related]
19. Mammotroph autoregulation: intracellular fate of internalized prolactin.
Giss BJ; Walker AM
Mol Cell Endocrinol; 1985 Oct; 42(3):259-67. PubMed ID: 4043520
[TBL] [Abstract][Full Text] [Related]
20. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
